| Small-molecule MYC inhibitors suppress tumor growth and enhance immunotherapy H Han, AD Jain, MI Truica, J Izquierdo-Ferrer, JF Anker, B Lysy, V Sagar, ... Cancer cell 36 (5), 483-497. e15, 2019 | 355 | 2019 |
| Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer R Vatapalli, V Sagar, Y Rodriguez, JC Zhao, K Unno, S Pamarthy, B Lysy, ... Nature communications 11 (1), 4153, 2020 | 90 | 2020 |
| EPHB4 inhibition activates ER stress to promote immunogenic cell death of prostate cancer cells V Sagar, R Vatapalli, B Lysy, S Pamarthy, JF Anker, Y Rodriguez, H Han, ... Cell death & disease 10 (11), 801, 2019 | 49 | 2019 |
| Activated ALK cooperates with N-Myc via Wnt/β-catenin signaling to induce neuroendocrine prostate cancer K Unno, ZR Chalmers, S Pamarthy, R Vatapalli, Y Rodriguez, B Lysy, ... Cancer research 81 (8), 2157-2170, 2021 | 47 | 2021 |
| Effective participatory science education in a diverse Latin American population LMR Ferreira, GA Carosso, N Montellano Duran, SV Bohorquez-Massud, ... Palgrave Communications 5 (1), 2019 | 36 | 2019 |
| Telmisartan protects a microglia cell line from LPS injury beyond AT1 receptor blockade or PPARγ activation AG Elkahloun, Y Rodriguez, S Alaiyed, E Wenzel, JM Saavedra Molecular neurobiology 56, 3193-3210, 2019 | 26 | 2019 |
| Angiopoietin-2 is a negative prognostic marker in small cell lung cancer I Cañadas, Á Taus, X Villanueva, O Arpí, L Pijuan, Y Rodríguez, ... Lung Cancer 90 (2), 302-306, 2015 | 22 | 2015 |
| A genome-wide CRISPR activation screen identifies PRRX2 as a regulator of enzalutamide resistance in prostate cancer Y Rodríguez, K Unno, MI Truica, ZR Chalmers, YA Yoo, R Vatapalli, ... Cancer research 82 (11), 2110-2123, 2022 | 19 | 2022 |
| MiR-150-5p overexpression in triple-negative breast cancer contributes to the in vitro aggressiveness of this breast cancer subtype BM Sugita, Y Rodriguez, AS Fonseca, E Nunes Souza, B Kallakury, ... Cancers 14 (9), 2156, 2022 | 19 | 2022 |
| Inflammatory bowel disease induces inflammatory and pre-neoplastic changes in the prostate AS Desai, V Sagar, B Lysy, AB Weiner, OS Ko, C Driscoll, Y Rodriguez, ... Prostate cancer and prostatic diseases 25 (3), 463-471, 2022 | 13 | 2022 |
| Asparagine Dependency Is a Targetable Metabolic Vulnerability in TP53-Altered Castration-Resistant Prostate Cancer YA Yoo, S Quan, W Yang, Q Guo, Y Rodríguez, ZR Chalmers, MF Dufficy, ... Cancer Research 84 (18), 3004-3022, 2024 | 5 | 2024 |
| Posttranslational Changes in Histone Modification Driven By USP48 Loss Increase Sensitivity to Hypomethylating Agents in Acute Myeloid Leukemia C Schneider, G Alexe, A Meyer, LA Merickel, AT Basanthakumar, ... Blood 144, 205, 2024 | | 2024 |
| ADAR1 Is a Vulnerability in TP53-Mutant Acute Myeloid Leukemia Y Rodriguez, G Alexe, A Taillon, C Schneider, K Stegmaier Blood 144, 2717, 2024 | | 2024 |
| Abstract LB082: Genome-wide CRISPR activation screen identifies PRRX2 as an enzalutamide resistance gene in prostate cancer YR Rodriguez, K Unno, M Truica, ZR Chalmers, YA Yoo, R Vatapalli, ... Cancer Research 82 (12_Supplement), LB082-LB082, 2022 | | 2022 |
| Inflammatory bowel disease induces inflammatory and preneoplastic changes in the prostate (May, 10.1038/s41391-021-00392-7, 2021) AS Desai, V Sagar, B Lysy, AB Weiner, OS Ko, C Driscoll, Y Rodriguez, ... PROSTATE CANCER AND PROSTATIC DISEASES 25 (2), 375-375, 2022 | | 2022 |
| Correction: Inflammatory bowel disease induces inflammatory and preneoplastic changes in the prostate AS Desai, V Sagar, B Lysy, AB Weiner, OS Ko, C Driscoll, Y Rodriguez, ... Prostate cancer and prostatic diseases 25 (2), 375, 2022 | | 2022 |
| Genome-wide CRISPRa screen reveals new drivers of Enzalutamide resistance in prostate cancer Y Rodriguez, R Vatapalli, H Han, K Unno, V Sagar, Z Chalmers, B Lysy, ... Cancer Research 80 (16_Supplement), 4102-4102, 2020 | | 2020 |
| Implementing participatory immunology education in a diverse Latin American student population L Ferreira, GA Carosso, NM Duran, S Bohorquez-Massud, G Vaca-Diez, ... The Journal of Immunology 204 (1_Supplement), 222.19-222.19, 2020 | | 2020 |
| MP16-19 MODELING THE IMPACT OF INFLAMMATORY BOWEL DISEASE ON PROSTATE CANCER RISK IN MICE: PRELIMINARY RESULTS OF AN ONGOING STUDY A Desai, B Lysy, V Sagar, RJ Vatapalli, HY Han, K Unno, YR Rodriguez, ... Journal of Urology 203, e222-e223, 2020 | | 2020 |
| Perceptions and prospects in life sciences in a heterogeneous Latin American population LMR Ferreira, GA Carosso, B Lopez-Videla, GV Diez, ... bioRxiv, 514216, 2019 | | 2019 |
